Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study

Nusinersen offers life-changing benefits for children with SMA, particularly those with more severe forms of the disorder. Caregiver assessments are positive. Nevertheless, patients remain severely disabled and still require intensive support care. This new treatment raises new ethical challenges.